Abolis Biotechnologies raised €35M in a funding round in Sep 2024. The company is based in Evry, France. Investors in the round: BOLD , Clay Capital, DeepTech & Climate Fonds and 3 others. Data as of 21 Sept 2026.
Reported in EUR — no conversion. €35M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
